Pro-Dex, Inc.

NasdaqCM PDEX

Pro-Dex, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2024: 9.90%

Pro-Dex, Inc. Return on Assets (ROA) is 9.90% for the Trailing 12 Months (TTM) ending September 30, 2024, a -14.74% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Pro-Dex, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2023 was 11.61%, a 36.02% change year over year.
Pro-Dex, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2022 was 8.53%, a -18.20% change year over year.
Pro-Dex, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2021 was 10.43%, a -50.57% change year over year.
Pro-Dex, Inc. Return on Assets (ROA) for the Trailing 12 Months (TTM) ending September 30, 2020 was 21.11%, a 39.46% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

NasdaqCM: PDEX

Pro-Dex, Inc.

CEO	Mr. Richard Lee Van Kirk Jr.
IPO Date	Aug. 7, 1986
Location	United States
Headquarters	2361 McGaw Avenue
Employees	146
Sector	Health Care
Industries Medical Instruments

Description

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Key trends

Past 5 years